Search For "covid 19 vaccine trials"
COVID-19: Second dose trial of Covaxin on 2-6 years to begin by next week
Updated : 4 years, 7 months ago IST
New Delhi [India], July 23 (ANI): As part of its COVID-19 vaccination trials for children, Bharat Biotech is likely to administer the second dose of Covaxin to children aged between 2 and 6 years next week, sources said on Thursday.
Read More
'Submit results on Covavax adult trials first': Govt panel to SII on Covid
Updated : 4 years, 8 months ago IST
New Delhi [India], July 1 (ANI): An expert panel constituted by the government has recommended against granting permission to the Serum Institute of India (SII) to conduct phase two and three clinical trials of Covavax COVID-19 vaccine on children aged between 2-17 years, said sources on
Read More
Johnson & Johnson won't be conducting COVID-19 vaccine trials in India
Updated : 4 years, 8 months ago IST
New Delhi [India], June 29 (ANI): Johnson & Johnson will not be conducting local trials in India for its single-dose COVID-19 vaccine, a spokesperson of the US-based pharma company said on Tuesday.
Read More
Israel to start phase 2 of COVID-19 vaccine trials in coming days, says De
Updated : 5 years, 2 months ago IST
Tel Aviv [Israel], December 15 (ANI/Sputnik): The Israel Institute for Biological Research (IIBR) has successfully completed phase one of the domestic coronavirus vaccine trials and plans to start phase two of the clinical trials in the coming days, the Israeli Defense Ministry said on Monda
Read More
China's COVID-19 vaccine trials suspended in Brazil after 'severe incident
Updated : 5 years, 4 months ago IST
Brasilia [Brazil], November 10 (ANI): Brazil's health regulator Anvisa said on Monday it has suspended clinical trials of China's Sinovac COVID-19 vaccine, following a "severe incident".
Read More
Equity indices shed early losses, financials and banking stocks lead
Updated : 5 years, 5 months ago IST
Mumbai (Maharashtra) [India], Oct 14 (ANI): Equity benchmark indices witnessed a sharp recovery in the last hour of trading session on Wednesday and closed in the green led by a rally in financial and banking scrips.
Read More
Equity indices tumble amid weak global cues, banking and IT stocks suffer
Updated : 5 years, 5 months ago IST
Mumbai (Maharashtra) [India], October 14 (ANI): Equity benchmark indices tumbled over half per cent during early hours on Wednesday tracking Asian peers as halted COVID-19 vaccine trials soured investor risk appetite.
Read More
US President urges citizens to enroll in COVID-19 vaccine trials
Updated : 5 years, 5 months ago IST
Washington [US], September 24 (ANI): Urging the US citizens to participate in COVID-19 vaccine trials, President Donald Trump on Wednesday (local time) said Johnson & Johnson has announced that their vaccine candidate has reached the final stage of clinical trials.
Read More
Suspension of AstraZeneca COVID-19 vaccine trials showed fallacy of approa
Updated : 5 years, 6 months ago IST
Moscow [Russia], September 13 (ANI): Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev on Saturday said that temporary suspension of AstraZeneca COVID-19 vaccine candidate trials clearly showed the "fallacy of the approach" when countries "exclusively rely on novel and untested platf
Read More
Serum Institute to resume COVID-19 vaccine trials in India after DCGI nod
Updated : 5 years, 6 months ago IST
New Delhi [India], September 12 (ANI): Hours after clinical trials for AstraZeneca and Oxford University coronavirus vaccine resumed on Saturday in the UK, pharma major Serum Institute of India (SII) said it will resume the trials in India once Drugs Controller General of India (DCGI) gives
Read More
Equity gauges end flat amid gloomy investor sentiment
Updated : 5 years, 6 months ago IST
Mumbai (Maharashtra) [India], September 11 (ANI): Equity benchmark indices closed at near-flat levels on Friday as investors remained cautious about adverse news flow of Covid-19 vaccine trials, simmering India-China geopolitical tensions and a sharp sell-off in US equities.
Read More
Oxford COVID-19 vaccine trials not paused in India, clarifies Serum Instit
Updated : 5 years, 6 months ago IST
New Delhi [India], September 9 (ANI): After AstraZeneca suspended the trials of COVID-19 vaccine in the UK, Indian pharmaceutical giant Serum Institue of India (SII) on Wednesday clarified that testing of the possible vaccine candidate in India is ongoing and has not faced any issue so far.
Read More